267. When Does PK/PD Matter for Patient Care?
Saturday, October 6, 2018: 2:00 PM-3:15 PM
Room: S 305-314
University of Wisconsin

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the clinical relevance of antibiotic pharmacokinetics
  • explain when adjustment may be needed for optimal therapy
  • discuss the literature exploring the impact of organ specific antibiotic pharmacokinetics

Target Audience: Academicians, Clinicians, Infectious diseases pediatricians, Infectious diseases physicians, Pharmacists, Researchers, Scientists

Tracks: Trainee, Pediatric ID, Investigative ID, Adult ID

Moderators:  David R. Andes, M.D., FIDSA, University of Wisconsin School of Medicine and Public Health , Cesar Arias, MD, PhD, FIDSA, University of Texas Health Science Center at Houston and Robert Bonomo, MD, Louis Stokes Cleveland VA Medical Center

2:00 PM
Dosing Antibiotics in the ICU
Sujata M. Bhavnani, Pharm.D., M.S.

2:25 PM
AUC-Guided Vancomycin Therapy for Physicians
Michael Neely, MD, MSc, FCP

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-277-L04-P


D. R. Andes, None

C. Arias, Merck & Co., Inc.: Grant Investigator , Research support . MeMed: Grant Investigator , Research support . Allergan: Grant Investigator , Research support .

R. Bonomo, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.